摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Cp*Ir(PMe3)(η2-C6H3-44Me(CO2Me)C=C(CO2Me)) | 173203-20-8

中文名称
——
中文别名
——
英文名称
Cp*Ir(PMe3)(η2-C6H3-44Me(CO2Me)C=C(CO2Me))
英文别名
dimethyl 2-(3-methylbenzene-6-id-1-yl)but-2-enedioate;iridium(3+);1,2,3,4,5-pentamethylcyclopenta-1,3-diene;trimethylphosphane
Cp*Ir(PMe3)(η2-C6H3-44Me(CO2Me)C=C(CO2Me))化学式
CAS
173203-20-8
化学式
C26H36IrO4P
mdl
——
分子量
635.763
InChiKey
KGFIATZUDRIKMA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.63
  • 重原子数:
    32
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    52.6
  • 氢给体数:
    0
  • 氢受体数:
    7

反应信息

  • 作为产物:
    描述:
    Cp*Ir(PMe3)(p-tolyl)F 、 丁炔二酸二甲酯 为溶剂, 以80%的产率得到Cp*Ir(PMe3)(η2-C6H3-44Me(CO2Me)C=C(CO2Me))
    参考文献:
    名称:
    Synthesis and Chemistry of the Aryliridium(III) Fluorides Cp'Ir(PMe3)(Aryl)F: High Reactivity due to Surprisingly Easy Ir-F Ionization
    摘要:
    This paper reports the synthesis and chemistry of the unusual late metal fluoride complexes, Cp'Ir-(PMe(3))(Aryl)F [Cp' = Cp* (C(5)Me(5)), Aryl = Ph (1a); Cp' = Cp*, Aryl = p-tolyl (1b); Cp' = Cp(Et) (C(5)Me(4)Et), Aryl = Ph(1c)]. The solid-state structure of Ic has been determined: crystals of 1c are monoclinic, space group P2(1)/c, with a = 9.235(2) Angstrom, b = 12.667(2) Angstrom, c = 17.129(3) Angstrom, beta 104.547(16)degrees, and Z = 4; R = 3.98%, wR = 4.65% for 2859 data for F-2 > 3 sigma(F-2). These complexes exhibit reactivity that is substantially different from that of related Cl, Pr, and I species because of the greater propensity of fluoride ion to dissociate from the Ir center, even in nonpolar solvents. For example, in solution at room temperature, fluoride is slowly displaced from complexes 1 by Lewis bases such as pyridines and phosphines (L); the resulting salts [Cp'Ir(PMe(3))(Aryl)(L)]F (2) exist in equilibrium with the covalent starting materials. This equilibrium Lies well to the left for pyridines and phosphines under anhydrous conditions, but both the rate of establishment and the magnitude of K-eq are increased dramatically by the addition of H2O. In aqueous THF the aquo species [Cp*Ir(PMe(3))(Ph)(OH2)]F . xH(2)O (2e) is formed much more rapidly than the [Cp'Ir(PMe(3))(Aryl)(L)]F salts. This, and the rapid further reactivity of 2e, enables the aquo species to serve as an intermediate in the water-catalyzed substitution of fluoride by L. Treatment of la with mixtures of water and other entering ligands and monitoring these reactions over time reveals that the kinetic affinity of these ligands for the Ir center is exactly the reverse of their thermodynamic affinity: kinetically, H2O > pyridines > phosphines; thermodynamically, phosphines > pyridines > H2O. Addition of BPh(3) to [Cp'Ir(PMe(3))(Aryl)(L)]F (2) in nonaqueous media leads to irreversible formation of the berate complexes, [Cp'Ir(PMe(3))(Aryl)(L)]BPh(3)F. The lability of the fluoride Ligand in complexes 1 is also demonstrated by mixing Cp*Ir(PMe(3))(Ph)F with Cp*Ir(PMe(3))(p-tolyl)X IX Cl, Pr, OTf, OPh] in C6D6, which leads to solutions containing four species identifiable as the two starting materials and the two exchange products Cp*Ir(PMe(3))Ph)X and Cp*Ir(PMe(3))p-tolyl)F. Organic halides participate in exchange as well; reaction of la with PhCH(2)Br, Me(3)SiCl, MeCOCl, and even CH2Cl2 results in complete replacement of fluoride by bromide or chloride in la. The labile fluoride ion also leads to other novel reactivity. For example, addition of dimethyl acetylenedicarboxylate to complexes 1 gives iridacyclopentadiene complexes (5) and reaction of la and Ic with (l-trimethylsilyl)imidazole provides Cp'Ir(PMe(3))(Ph)(imidazolate) complexes (7) and Me(3)SiF. Treatment of 1 with silanes HSiMe(2)R [R = Ph, Me] leads to the formation of Cp'Ir(PMe(3))(R)(SiMe(2)F) complexes(8); excess HS-p-tolyl reacts with either 1a or 1b to provide Cp*Ir(PMe(3))(S-p-tolyl)(2) (10).
    DOI:
    10.1021/ja00155a012
点击查看最新优质反应信息

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)